Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-24 10:28 am Purchase | 2021-12-31 | 13G | CIS Acquisition Ltd. | Empery Asset Management LP | 3,900,000 4.990% | 3,900,000 (New Position) | Filing History |
| 2022-01-20 09:55 am Purchase | 2021-12-31 | 13G | Peraso Inc. PRSO | Empery Asset Management LP | 184 0.080% | 184 (New Position) | Filing History |
| 2022-01-20 09:53 am Sale | 2021-12-31 | 13G | Pyxis Tankers Inc. PXS | Empery Asset Management LP | 40,000 0.420% | -674,286 (-94.40%) | Filing History |
| 2022-01-20 09:51 am Sale | 2021-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Empery Asset Management LP | 7,306 4.990% | -1,024 (-12.30%) | Filing History |
| 2022-01-20 09:49 am Purchase | 2021-12-31 | 13G | Nuwellis, Inc. NUWE | Empery Asset Management LP | 137 4.350% | 137 (New Position) | Filing History |
| 2022-01-20 09:47 am Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Empery Asset Management LP | 33,333 2.520% | -760 (-2.23%) | Filing History |
| 2022-01-19 11:04 am Sale | 2021-12-31 | 13G | Applied Genetic Technologies Corporation AGTC | Empery Asset Management LP | 2,244,292 4.990% | -1,688,292 (-42.93%) | Filing History |
| 2022-01-19 11:03 am Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Empery Asset Management LP | 471,579 4.740% | 471,579 (New Position) | Filing History |
| 2022-01-19 10:48 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 336 0.440% | -3,664 (-91.61%) | Filing History |
| 2022-01-19 10:46 am Purchase | 2021-12-31 | 13G | Envirotech Vehicles, Inc. EVTV | Empery Asset Management LP | 20,139 2.610% | 20,139 (New Position) | Filing History |
| 2022-01-19 10:44 am Sale | 2021-12-31 | 13G | Caladrius Biosciences, Inc. CLBS | Empery Asset Management LP | 167,024 4.020% | -62,908 (-27.36%) | Filing History |
| 2022-01-18 11:21 am Unchanged | 2021-12-31 | 13G | Viveve Medical, Inc. VIVE | Empery Asset Management LP | 1,029,411 4.990% | 0 (Unchanged) | Filing History |
| 2022-01-18 11:19 am Purchase | 2021-12-31 | 13G | Timber Pharmaceuticals, Inc. TMBR | Empery Asset Management LP | 197,331 4.990% | 15,625 (+8.60%) | Filing History |
| 2022-01-18 11:17 am Purchase | 2021-12-31 | 13G | Opus Genetics, Inc. IRD | Empery Asset Management LP | 3,063,498 4.990% | 384,615 (+14.36%) | Filing History |
| 2022-01-18 11:14 am Purchase | 2021-12-31 | 13G | Castor Maritime Inc. CTRM | Empery Asset Management LP | 306,786 3.300% | 306,786 (New Position) | Filing History |
| 2022-01-18 11:12 am Unchanged | 2021-12-31 | 13G | Ring Energy, Inc. REI | Empery Asset Management LP | 21,428,500 4.990% | 0 (Unchanged) | Filing History |
| 2022-01-13 10:38 am Sale | 2021-12-31 | 13G | Red Cat Holdings, Inc. RCAT | Empery Asset Management LP | 0 0.000% | -3,000,000 (Position Closed) | Filing History |
| 2022-01-13 10:37 am Sale | 2021-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management LP | 0 0.000% | -33,333 (Position Closed) | Filing History |
| 2022-01-13 10:36 am Sale | 2021-12-31 | 13G | Second Sight Medical Products, Inc. EYES | Empery Asset Management LP | 0 0.000% | -1,100,000 (Position Closed) | Filing History |
| 2022-01-13 10:36 am Sale | 2021-12-31 | 13G | Atossa Therapeutics, Inc. ATOS | Empery Asset Management LP | 1,312,500 1.030% | -3,448,000 (-72.43%) | Filing History |